Genentech’s parent company Roche said the $850m deal lines up with its plan to focus on three therapeutic areas including ...

CDK Global has successfully renewed its DMS agreement with Sonic Automotive, securing a key partnership following two ...

CDK, the leading automotive retail software provider, today announced the extension of its agreement with Sonic Automotive, ...

The news reinforces CDK's reputation in the DMS business and, presumably, will help the company land more extensions and new ...

The contract extension with Sonic is a win for market leader CDK, which faced challenges over the summer after two ...

Meanwhile, the acquisition of AntlerA, which Roche called a leader in Wnt signaling, gives the pharma ownership of a library ...

In Hybrids amidst financial challenges. Read More CDK Global extends DMS contract with Sonic Automotive amid cyberattack ...

It hasn’t been the best of years for CDK Global, but it got some good news Monday. Sonic Automotive, one of the nation’s ...

Genentech has acquired Regor Pharmaceuticals’ next-generation CDK inhibitors for breast cancer treatment in a deal worth ...

Cambridge, Massachusetts-based biotech Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors for the ...

DelveInsight's CDK 7 Inhibitors Market Insights report includes a comprehensive understanding of current treatment practices, ...

Roche is spending $850 million upfront to buy Regor Pharmaceuticals’ suite of next-generation CDK inhibitors as it doubles ...